Timothy Sullivan Honored by Medical Device & Diagnostic Industry Magazine
Timothy Sullivan, President and CEO of Mystic Pharmaceuticals, has been recognized by the editors of Medical Device & Diagnostic Industry as one of the magazine’s […]
Rapture: AngioDynamics’ Lung Cancer Treatment Shows Promise
Back in 2004, shares of Rita Medical surged as much as 67 percent after it reported positive results for its radio-frequency ablation (RFA) technology in […]
Arizona Prisoners Can Take Heart
CompuMed will provide remote cardiac screening on an as needed basis for more than 30,000 Arizona state prisoners. The Arizona Department of Corrections has been […]
AngioDynamics Recall: No Biggie
AngioDynamics has initiated a voluntary recall of its Centros central venous catheter for dialysis. The company became aware that the catheter cuff (the component used […]
Biolase Unveils More Affordable Dental Laser
Biolase Technology has launched a new hard and soft tissue laser for restorative general dentists, the Waterlase C100. The device is priced to appeal to […]
Bioject and Merial to Jointly Develop an Animal Vaccine Delivery System
Bioject Medical, a developer of needle-free technologies, has signed an exclusive, long term development and supply agreement with Merial Limited for an animal vaccine delivery […]
[Quick Take] Interview with Vijay Aggarwal, CEO of Aureon Laboratories
Aureon Laboratories is developing predictive and personalized cancer treatment options. Aureon employs a unique ‘systems pathology’ approach to provide personalized test results by analyzing a […]
Inovio Biomedical and VGX Pharmaceuticals to Merge
Citing synergies, Inovio Biomedical and VGX Pharmaceuticals have announced merger plans. Inovio’s electroporation technology uses brief, controlled electrical pulses to increase cellular uptake of gene […]
Chembio to Screen Teens with HIV Rapid Tests
Chembio Diagnostics has completed a clinical study evaluating the performance of its two FDA approved rapid HIV tests in teens 13-17 years old. The objective […]
Despite Steady Progress, Applied NeuroSolutions Struggles
Applied NeuroSolutions (APNS), an IL-based firm developing products for the diagnosis and treatment of Alzheimer’s disease (AD), is struggling in penny stock land. Despite steady […]